In-vitro Toxicology Testing Market Share

Statistics for the 2023 & 2024 In-vitro Toxicology Testing market share, created by Mordor Intelligence™ Industry Reports. In-vitro Toxicology Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of In-vitro Toxicology Testing Industry

The in-vitro toxicology testing market is highly competitive and consists of a few major players. Companies, such as Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Covance, Eurofins Scientific, GE Healthcare, Merck KGaA, Promega Corporation, Quest Diagnostics, and Thermo Fisher Scientific, among others, hold a substantial market share in the market studied.

Market entities are also engaged in expanding their market presence by entering untapped regions and collaborating with other smaller manufacturers that offer in-vitro assays. For instance, in August 2019, Abbott signed an agreement with Intoximeters, which gave Intoximeters exclusive distribution rights to Abbott's SoToxa Mobile Test System, a handheld oral fluid solution for drug and alcohol testing in the U.S. The product enables the testing of methamphetamine, benzodiazepines, amphetamine, cocaine, cannabis (THC), and opiates.

In Vitro Toxicology Testing Market Leaders

  1. Abbott Laboratories

  2. Bio-Rad Laboratories

  3. Covance

  4. Agilent Technologies

  5. Eurofins Scientific

*Disclaimer: Major Players sorted in no particular order

In-Vitro Toxicology Testing Market Concentration

In Vitro Toxicology Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)